Citation: Jr. Berenson, THE EFFICACY OF PAMIDRONATE DISODIUM IN THE TREATMENT OF OSTEOLYTIC LESIONS AND BONE PAIN IN MULTIPLE-MYELOMA, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 195-203
Citation: Nw. Clarke, THE EFFECTS OF PAMIDRONATE DISODIUM TREATMENT IN METASTATIC PROSTATE-CANCER, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 205-212
Citation: Sj. Houston et Rd. Rubens, THE TOLERABILITY AND ADVERSE EVENT PROFILE OF PAMIDRONATE DISODIUM, Reviews in contemporary pharmacotherapy, 9(3), 1998, pp. 213-224
Citation: J. Karle et M. Nielsen, THE MECHANISM OF ACTION AND PHARMACOLOGY OF ZOPICLONE, Reviews in contemporary pharmacotherapy, 9(2), 1998, pp. 77-87
Citation: E. Ruther et Mj. Parnham, THE EFFICACY AND SAFETY OF ZOPICLONE AS AN HYPNOTIC, Reviews in contemporary pharmacotherapy, 9(2), 1998, pp. 109-121
Citation: M. Lader, THE CONSEQUENCES OF ZOPICLONE USE - REBOUND INSOMNIA, DEVELOPMENT OF TOLERANCE, AND ABUSE POTENTIAL, Reviews in contemporary pharmacotherapy, 9(2), 1998, pp. 131-140
Citation: C. Idzikowski, ZOPICLONE, HEALTH-RELATED QUALITY-OF-LIFE, AND DAYTIME WELL-BEING, Reviews in contemporary pharmacotherapy, 9(2), 1998, pp. 141-146